Market Research Logo

NicOx S.A. - Product Pipeline Review - 2016

NicOx S.A. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘NicOx S.A. - Product Pipeline Review - 2016’, provides an overview of the NicOx S.A.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by NicOx S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of NicOx S.A.
  • The report provides overview of NicOx S.A. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses NicOx S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features NicOx S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate NicOx S.A.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for NicOx S.A.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding NicOx S.A.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


NicOx S.A. Snapshot
NicOx S.A. Overview
Key Information
Key Facts
NicOx S.A. - Research and Development Overview
Key Therapeutic Areas
NicOx S.A. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
NicOx S.A. - Pipeline Products Glance
NicOx S.A. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
NicOx S.A. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
NicOx S.A. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
NicOx S.A. - Drug Profiles
cetirizine hydrochloride
Product Description
Mechanism of Action
R&D Progress
naproxcinod
Product Description
Mechanism of Action
R&D Progress
azithromycin
Product Description
Mechanism of Action
R&D Progress
bromfenac sodium
Product Description
Mechanism of Action
R&D Progress
fluticasone propionate
Product Description
Mechanism of Action
R&D Progress
cerdulatinib
Product Description
Mechanism of Action
R&D Progress
ISV-405
Product Description
Mechanism of Action
R&D Progress
NCX-1021
Product Description
Mechanism of Action
R&D Progress
NCX-1653
Product Description
Mechanism of Action
R&D Progress
NCX-250
Product Description
Mechanism of Action
R&D Progress
NCX-422
Product Description
Mechanism of Action
R&D Progress
NCX-429
Product Description
Mechanism of Action
R&D Progress
NCX-434
Product Description
Mechanism of Action
R&D Progress
NCX-466
Product Description
Mechanism of Action
R&D Progress
NCX-470
Product Description
Mechanism of Action
R&D Progress
NCX-667
Product Description
Mechanism of Action
R&D Progress
NicOx S.A. - Pipeline Analysis
NicOx S.A. - Pipeline Products by Target
NicOx S.A. - Pipeline Products by Route of Administration
NicOx S.A. - Pipeline Products by Molecule Type
NicOx S.A. - Pipeline Products by Mechanism of Action
NicOx S.A. - Recent Pipeline Updates
NicOx S.A. - Dormant Projects
NicOx S.A. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
naproxcinod
NCX-1000
NCX-1236
NCX-226
NCX-285
NCX-6560
NicOx S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
NicOx S.A., Key Information
NicOx S.A., Key Facts
NicOx S.A. - Pipeline by Indication, 2016
NicOx S.A. - Pipeline by Stage of Development, 2016
NicOx S.A. - Monotherapy Products in Pipeline, 2016
NicOx S.A. - Partnered Products in Pipeline, 2016
NicOx S.A. - Partnered Products/ Combination Treatment Modalities, 2016
NicOx S.A. - Pre-Registration, 2016
NicOx S.A. - Filing rejected/Withdrawn, 2016
NicOx S.A. - Phase III, 2016
NicOx S.A. - Phase I, 2016
NicOx S.A. - Preclinical, 2016
NicOx S.A. - Pipeline by Target, 2016
NicOx S.A. - Pipeline by Route of Administration, 2016
NicOx S.A. - Pipeline by Molecule Type, 2016
NicOx S.A. - Pipeline Products by Mechanism of Action, 2016
NicOx S.A. - Recent Pipeline Updates, 2016
NicOx S.A. - Dormant Developmental Projects,2016
NicOx S.A. - Discontinued Pipeline Products, 2016
NicOx S.A., Subsidiaries
List of Figures
NicOx S.A. - Pipeline by Top 10 Indication, 2016
NicOx S.A. - Pipeline by Stage of Development, 2016
NicOx S.A. - Monotherapy Products in Pipeline, 2016
NicOx S.A. - Partnered Products in Pipeline, 2016
NicOx S.A. - Pipeline by Top 10 Target, 2016
NicOx S.A. - Pipeline by Route of Administration, 2016
NicOx S.A. - Pipeline by Molecule Type, 2016
NicOx S.A. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report